Effect of adenosine monophosphate deaminase-1 C34T allele on the requirement for donor inotropic support and on the incidence of early graft dysfunction after cardiac transplantation.

[1]  M. Yacoub,et al.  The effects of pre- and post-transplant anemia on 1-year survival after cardiac transplantation. , 2008, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[2]  Paul Aurora,et al.  Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult heart transplant report--2007. , 2007, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[3]  S. Agewall,et al.  Association between AMPD1 Gene Polymorphism and Coagulation Factors in Patients with Coronary Heart Disease , 2006, Pathophysiology of Haemostasis and Thrombosis.

[4]  P. Barton,et al.  Real-time quantitative polymerase chain reaction in cardiac transplant research. , 2006, Methods in molecular biology.

[5]  B. Horne,et al.  The role of a common adenosine monophosphate deaminase (AMPD)-1 polymorphism in outcomes of ischemic and nonischemic heart failure. , 2005, Journal of cardiac failure.

[6]  M. Yacoub,et al.  Association of Improved Cardiac Function in Donors with C34T Mutation of the AMP Deaminase 1 Gene , 2005, Nucleosides, nucleotides & nucleic acids.

[7]  B. Horne,et al.  A common variant of the AMPD1 gene predicts improved survival in patients with ischemic left ventricular dysfunction. , 2004, Journal of cardiac failure.

[8]  M. Yacoub,et al.  C34T AMP deaminase 1 gene mutation protects cardiac function in donors. , 2004, Transplantation.

[9]  D. Reinhardt,et al.  Role of adenosine monophosphate deaminase-1 gene polymorphism in patients with congestive heart failure (influence on tumor necrosis factor-alpha level and outcome). , 2004, The American journal of cardiology.

[10]  S. Shiboski,et al.  The impact of left ventricular dysfunction on cardiac donor transplant rates. , 1999, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[11]  A. Khaghani,et al.  Determinants of outcome after heterotopic heart transplantation. , 2002, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[12]  M. Goddard,et al.  The endothelium in clinical cardiac transplantation. , 2002, The Annals of thoracic surgery.

[13]  M. Yacoub,et al.  Elevated Tumor Necrosis Factor-&agr; and Interleukin-6 in Myocardium and Serum of Malfunctioning Donor Hearts , 2000, Circulation.

[14]  B. Horne,et al.  A common variant of the AMPD1 gene predicts improved cardiovascular survival in patients with coronary artery disease. , 2000, Journal of the American College of Cardiology.

[15]  A. Khaghani,et al.  Tumor necrosis factor-alpha is expressed in donor heart and predicts right ventricular failure after human heart transplantation. , 2000, Circulation.

[16]  R. Novick,et al.  The Registry of the International Society of Heart and Lung Transplantation: Third Official Pediatric Report-1999. , 1999, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[17]  R. Novick,et al.  The Registry of the International Society for Heart and Lung Transplantation: sixteenth official report--1999. , 1999, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[18]  T. Rebbeck,et al.  Common variant in AMPD1 gene predicts improved clinical outcome in patients with heart failure. , 1999, Circulation.

[19]  T. Rebbeck,et al.  Common Variant in AMPD 1 Gene Predicts Improved Clinical Outcome in Patients With Heart Failure , 1999 .

[20]  J. Shryock,et al.  Adenosine and adenosine receptors in the cardiovascular system: biochemistry, physiology, and pharmacology. , 1997, The American journal of cardiology.

[21]  E. Botvinick,et al.  Comparison of adenosine to dipyridamole in degree of coronary hyperemic response in heart transplant recipients. , 1996, The American journal of cardiology.

[22]  G. Hicks,et al.  ADENOSINE DEAMINASE INHIBITOR IN CARDIOPLEGIA ENHANCED FUNCTION PRESERVATION OF THE HYPOTHERMICALLY STORED RAT HEART , 1994, Transplantation.

[23]  M. Yacoub,et al.  Endothelial nucleotide catabolism and adenosine production , 1992 .

[24]  E. Arbustini,et al.  Electrocardiographic changes suggestive of myocardial ischemia elicited by dipyridamole infusion in acute rejection early after heart transplantation. , 1990, Circulation.